The largest database of trusted experimental protocols

Total cholesterol

Manufactured by Abcam
Sourced in United States

Total cholesterol is a laboratory test that measures the total amount of cholesterol in the blood, including both low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol. This assay provides a comprehensive assessment of an individual's overall cholesterol levels.

Automatically generated - may contain errors

4 protocols using total cholesterol

1

Cardiac Puncture for Plasma and Liver Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anaesthetised with isoflurane (2–3% carried in 2–3% O2) and blood samples were obtained via a cardiac puncture, using a heparinised syringe and needle (100 U/ml). Plasma was separated with centrifugation (400 × g, 20 min), snap frozen in liquid nitrogen and stored at −80 °C until processing. Whole liver was weighed and snap frozen in liquid nitrogen for biochemical assays. Plasma and hepatic triglyceride (TG) (Cayman, UK) and total cholesterol (Abcam, UK) were quantified as per manufacturer’s instructions. Plasma aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and gamma glutamyltransferase (GGT) levels were determined following manufactuer’s instructions (Sigma-Aldrich, UK). Plasma albumin was measured according to manufacturer’s instructions (Abcam, UK). Liver samples were homogenised in 0.125 M potassium phosphate buffer with protease inhibitors, as previously described19 (link); results were normalised to protein content.
+ Open protocol
+ Expand
2

Lipid Profile Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma total cholesterol (Abcam® Inc., Cambridge, MA, USA), triglyceride (Abcam® Inc., Cambridge, MA, USA), HDL-C (Abcam® Inc., Cambridge, MA, USA) and LDL-C + VLDL-C (Abcam® Inc., Cambridge, MA, USA) concentrations were determined using assay kits, according to manufacturer’s instructions. Sample and standard(s) optical density values were measured at 450 nm using a BioTek® Microplate Reader (Winooski, VT, USA).
+ Open protocol
+ Expand
3

Glucose-ABA Modulation of Metabolic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seven-week-old mice (nine/group) fed a standard chow were administered glucose in the drinking water without (controls) or with synthetic (±)-2-cis, 4-trans abscisic acid (ABA) (Sigma Aldrich, Milano, Italy). To achieve the required daily dose of glucose (1 g/Kg BW) and of ABA (1 µg/Kg BW), the daily volume of water drank by the animals was preliminarily established. Based on this volume (5 mL/day) and taking into account an average weight of the mice of 25 g, the water administered to the animals contained 0.005 g/mL of glucose and 0.005 µg/mL of ABA. The animals were weighed weekly and the concentrations of glucose and of ABA in the water were adjusted to the mean BW in each cage. After 4 months of treatment, blood was drawn after overnight fasting to measure HbA1c (Crystal Chem Inc., Elk Grove Village, IL, USA), total cholesterol, and triglycerides (Abcam, Cambridge, UK) and body weight was measured.
+ Open protocol
+ Expand
4

Metabolic Profiling of Mice on HFD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Food consumption and body weight were monitored weekly. After 18 weeks on an HFD as indicated, fasting blood glucose was measured. Serum was collected before mice were euthanized. Triglycerides, total cholesterol, LDL/VLDL, HDL, and insulin quantification kits were purchased from Abcam (Cambridge, MA), and ELISA detection was performed according to the manufacturer’s instructions. For glucose tolerance tests (GTTs), mice were fasted for 14 h and 1 g glucose/kg body wt i.p. was injected; for insulin tolerance tests (ITTs), mice were fasted for 6 h and 0.75 units/kg body wt i.p. recombinant human insulin (Invitrogen, Grand Island, NY) was injected. Blood glucose was measured at 0, 15, 30, 60, and 120 min after glucose or insulin injection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!